Bristol Myers Squibb EU Policy

Pros: The base salary for an EU Policy Analyst in Brussels is pretty competitive for the pharmaceutical industry. You get solid health benefits and a good pension plan, which is what you'd expect from a big pharma company. It's a stable employer in the biopharma space.
Cons: Bonuses aren't as generous as some other companies, especially considering the current EU regulatory landscape. There's not much room for salary negotiation once you're in, and stock options aren't a huge perk for policy roles here.
Advice to Management: Consider reviewing the bonus structure for policy teams to better reflect individual contributions and market standards in the EU. There's room to improve the overall compensation package to attract top talent for key policy roles.

Pros: The compensation for EU Policy roles is pretty strong, especially considering it's a major biopharma company. My pay and benefit package in the Brussels office included good health insurance and a solid pension plan. It definitely feels competitive for this industry.
Cons: While the base pay is good, I don't think the bonus structure is as generous as it could be for big pharma. Sometimes the benefits feel a bit standard, not super innovative. You might find better perks elsewhere if work flexibility is a huge priority.
Advice to Management: Revisit the bonus structure to be more competitive. Offer more options for work flexibility across the EU Policy team.

Pros: The team in the Brussels office is really supportive. I felt included, and there's a good sense of camaraderie among the EU policy folks. As an EU Policy Analyst, I got to work on some impactful healthcare policy issues.
Cons: It's a huge corporate structure, so bureaucracy can really slow things down. Sometimes, the overall company culture felt a bit detached from the day-to-day policy work. Decision-making for the pharmaceutical industry can be sluggish.
Advice to Management: Try to empower the local teams more and streamline some of the decision-making processes. It would help the EU Policy team be more agile.

Pros: As an EU Policy Analyst, you get decent exposure to complex healthcare policy and EU regulations. It's a solid name to have on your resume, especially in the big pharma world. The teams generally work well together in the Brussels office.
Cons: Career growth is pretty slow here, honestly. There aren't many clear advancement opportunities for regulatory affairs roles, which was frustrating. It's tough to move up internally, and internal rotations just don't happen often enough.
Advice to Management: Management should really look into creating clearer career progression frameworks for EU Policy and regulatory affairs positions. More internal mobility and defined pathways would help a lot with retention. People want to see a future here.

Pros: As an EU Policy Manager, the base salary is quite good, definitely competitive for big pharma in the Brussels office. They do have solid health insurance and some basic retirement plans which is standard for the pharmaceutical industry.
Cons: The bonus structure isn't as transparent as I'd like, and it feels a bit under market for this kind of corporate role. There aren't many extra perks or unique benefits beyond the basics, which other companies in EU health policy offer.
Advice to Management: Re-evaluate the bonus system and consider enhancing unique benefits to truly attract and retain top talent in EU policy roles, especially compared to other big pharma players in the region.

Pros: Working as an Associate Director in EU Policy here means you're tackling big issues in the biopharmaceutical industry. The work itself is really engaging, especially navigating the complex EU regulatory landscape. You get good exposure and it's a decent learning environment for healthcare policy professionals.
Cons: Job security for policy roles can feel a bit uncertain sometimes, especially with constant changes in EU directives. The workload can get heavy, impacting work-life balance, and there's not always clear communication about big internal shifts. We often have to be in the Brussels office, limiting work flexibility.
Advice to Management: Focus on clearer communication regarding team structure and future policy shifts impacting job security for policy professionals. Improving work-life balance and offering more work from home options would boost morale.

Pros: You learn a lot about the pharmaceutical industry's policy side. There's good exposure to EU regulatory processes. As an EU Policy Manager, I gained solid project experience and the Brussels office offered decent networking.
Cons: Career growth here is pretty slow for policy professionals. Internal promotions don't happen often, especially if you're not in R&D. There isn't a super clear path for moving up beyond senior manager, which can be frustrating.
Advice to Management: Invest more in career development plans for non-R&D staff. Create clearer progression paths for policy and government affairs roles.

Pros: I like the hybrid work arrangement. We get two WFH days a week, which is really helpful for work-life balance. For EU regulatory roles, having that flexibility to focus without constant office interruptions is a huge plus. The Brussels office is central and well-equipped for the days we're in.
Cons: The two WFH days are set, so there isn't much personal flexibility beyond that. If you need more remote options, it's tough. I wish there was more trust to truly work from anywhere, especially for senior policy roles. It feels a bit rigid for a big pharma company.
Advice to Management: Give more autonomy regarding remote work days for experienced EU policy professionals. Trust your teams to manage their time and locations effectively; true work flexibility can boost morale and productivity.

Pros: I've really appreciated the hybrid model here. As an EU Policy Manager, I can usually work from home a couple of days a week, which is great for personal appointments and avoiding the Brussels commute. It's solid flexibility for a big corporate pharma company.
Cons: However, while the WFH option is there, the workload in policy affairs can be intense. Sometimes it feels like you're always on, even with the flexible schedule. It can make actual work-life balance tough, despite the flexible policy.
Advice to Management: Try to better manage workload expectations, especially for EU Policy teams. The hybrid model is great, but it needs to truly support work-life balance, not just offer remote work.

Pros: I've found there's good flexibility, especially with the hybrid model. As an EU Policy Specialist, I can often work from home a couple of days a week. This really helps with personal appointments or just avoiding the Brussels commute.
Cons: The workload can get intense, especially around key legislative deadlines in the pharmaceutical industry. Sometimes it feels like there aren't enough resources, so you end up working longer hours. It's tough to consistently stick to 40-hour weeks.
Advice to Management: Try to better manage the workload expectations for the EU policy team. Investing in more staffing could prevent burnout and ensure better project delivery during peak times. A clearer path for career progression would also be great.